ATM and cervical carcinoma: To our knowledge, this is the first time that ATM and 53BP1 have been assessed by immunohistochemistry in their activated phosphorylated state in a large, well-documented and consecutive series of patients with cervical cancer primarily treated with (chemo)radiation.